Related references
Note: Only part of the references are listed.A Tutorial for Pharmacogenomics Implementation Through End-to-End Clinical Decision Support Based on Ten Years of Experience from PREDICT
Michelle Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics
Dianbo Liu et al.
GENETICS IN MEDICINE (2021)
Information blocking remains prevalent at the start of 21st Century Cures Act: results from a survey of health information exchange organizations
Jordan Everson et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program
Olivia M. Dong et al.
PHARMACOGENOMICS (2021)
Expanding evidence leads to new pharmacogenomics payer coverage
Philip E. Empey et al.
GENETICS IN MEDICINE (2021)
The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later
Mary V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic
Meghan J. Arwood et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Pharmacogenomics for Primary Care: An Overview
Victoria Rollinson et al.
GENES (2020)
Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists
Roseann S. Gammal et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2019)
Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre-emptive pharmacogenomic testing
James E. Kimpton et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
The All of Us Research Program
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Gene-Based Prescribing Is Here. Are Providers Ready?
Leland E. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users
Catherine Chanfreau-Coffinier et al.
JAMA NETWORK OPEN (2019)
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
Philip E. Empey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
Kelly E. Caudle et al.
GENETICS IN MEDICINE (2017)
Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system
Keith Danahey et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2017)
Implementation of a multidisciplinary pharmacogenomics clinic in a community health system
Henry M. Dunnenberger et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Integrating pharmacogenomics into electronic health records with clinical decision support
J. Kevin Hicks et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Henry M. Dunnenberger et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
PG4KDS: A model for the clinical implementation of pre-emptive pharmacogenetics
James M. Hoffman et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2014)
Share Paper
